request Request a Protocol
ask Ask a question
Favorite

The Cyclooxygenase enzymes (COX-1 and 2) inhibitory potential of our test compounds was determined according to the previously reported procedure [64]. Initially, different concentrations of the test compounds, ranging from 62.50 to 1000 μg/mL, were prepared. The enzyme solutions with a concentration of 0.7–0.8 μg/10 μL (COX-1) and 300 U/mL (COX-2) were prepared. To start the assay, for enzyme activation, 10 µL enzyme solution (kept in a cool temperature of 4 °C for 5 min) and cofactor containing hematin (50 µL, 1 mM), glutathione (0.9 mM) and TMPD in a Tris-buffer (0.1 M) with a pH 8.0 was added. After that, 60 µL of the enzyme solution was added to 20 µL of the test samples of various concentrations and incubated at room temperature for 5 to 10 min. Then, 20 µL of arachidonic acid (30 mM) was added to start the reaction. The mixture was then again incubated for 15 min at 37 °C, and absorbances were measured at 570 nm with UV-visible spectrophotometer. In this assay, the standard drug was aspirin and celecoxib for COX-1 and COX-2 enzymes, respectively. The % enzyme inhibitions were calculated by using the previously reported formula.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A